The MEA Pregnancy Testing Market size is expected to grow USD 0.21 Billion by 2027 from USD 0.16 Billion in 2022, growing at a CAGR of 5.35% between 2022 to 2027.
The MEA pregnancy testing market is poised to witness a rise owing to the rapid increase in demand for various pregnancy test kits because these kits are equipped with several cutting-edge innovations such as smart countdown technology, near-accurate results, and Bluetooth connectivity is, leading key pharmaceutical companies to focus on latest innovative formulation technologies. In addition, other factors such as effective reimbursement policies and cost reduction are analyzed to provide lucrative growth opportunities for market players.
Moreover, there is also an increase in professional women who have little time to seek medical help. In such scenarios, Direct-to-consumer (DTC) medical testing such as digital or rapid pregnancy kits is a great option to help people across the globe. Manufacturers offer pregnancy test kits and combination packs with fertility level checks, which are used to qualitatively detect the presence of the HCG hormone in urine and blood. Hence, pregnancy testing is gaining popularity, driving market growth.
Increased awareness of the availability of pregnancy detection kits, growing awareness of pregnancy self-detection kits and their benefits, and the growing demand for pregnancy self-detection kits are also driving the MEA pregnancy testing market. In addition, the increasing rate of teenage pregnancies, promotional campaigns, government initiatives to check on unplanned pregnancies, technological advancements in pregnancy kits, and easy availability of pregnancy testing kits via online websites, pharmacies, and retail stores will provide the market will several growth opportunities in the future.
However, several factors such as the lack of awareness and inaccurate results hamper the MEA pregnancy testing market. Lack of buyers in emerging economies and high infertility rates in countries such as South Africa, Nigeria, and Morocco, and the inability to purchase products due to insufficient finances may hinder the market growth. In addition, most test kits claim to be 99% accurate, which may lead to the possibility of false results in uncertain circumstances. The market is highly competitive, with several local and established players struggling to retain their market share. All these factors will harm the studied market during the forecast period.
This research report on the MEA pregnancy testing market has been segmented and sub-segmented into the following categories:
By Test Type:
By Distribution Channel:
In 2022, the regional market in Saudi Arabia dominated the MEA market and is predicted to continue to be the largest market generating region during the forecast period. This growth can be attributed to various factors such as increased awareness among women, high demand for pregnancy self-detection kits, improving healthcare facilities, an increase in the rate of unwanted pregnancies, the presence of favorable government initiatives related to family planning. As a result, Saudi Arabia's birth rate in 2022 was recorded to be 16,631 births per 1,000 population, a decrease of 2.73% from the year 2020.
The United Arab Emirates and South Africa are estimated to become major regional markets anticipated to grow at the highest CAGR due to the growing adoption of pregnancy detection kits in rural areas, increased awareness of the benefits of early pregnancy detection, adequate reimbursement policies, rising population, and increased disposable income. In addition, the latest report from the Gauteng Department of Health showed that more than 23,000 girls under 18 became teenage moms, of whom 934 were under the age of 14.
KEY MARKET PLAYERS:
Companies playing a promising role in the MEA Pregnancy Testing Market are Abbott Laboratories, Cardinal Health, Church & Dwight, Germaine Laboratories, Kent Pharmaceuticals, Piramal Enterprises, Prestige Brands Holdings, Procter & Gamble Co., Quidel Corporation, and SPD Swiss Precision Diagnostics.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com